SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-099708
Filing Date
2023-09-11
Accepted
2023-09-11 16:30:13
Documents
15
Period of Report
2023-06-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2325734d1_8ka.htm   iXBRL 8-K/A 31853
2 EXHIBIT 23.1 tm2325734d1_ex23-1.htm EX-23.1 7879
3 EXHIBIT 99.1 tm2325734d1_ex99-1.htm EX-99.1 1293404
4 EXHIBIT 99.2 tm2325734d1_ex99-2.htm EX-99.2 290439
  Complete submission text file 0001104659-23-099708.txt   1952541

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230629.xsd EX-101.SCH 3033
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230629_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230629_pre.xml EX-101.PRE 22371
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2325734d1_8ka_htm.xml XML 3330
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34620 | Film No.: 231248110
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences